Macrogenics, Inc.
Overview
MacroGenics, Inc. is a biotechnology company focused on discovering and developing innovative monoclonal antibody-based therapies for the treatment of cancer. The company utilizes its proprietary antibody-based technologies to advance a diverse portfolio of products, from early stage development to late stage clinical trials.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Macrogenics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Adventris Pharmaceuticals
United States
Alpha Oncology Therapeutics, Inc.
USA
Aulos Bioscience, Inc.
United States
Cancer Research Innovations, Inc.
USA
Checkpoint Therapeutics, Inc.
United States
Eureka Therapeutics, Inc.
United States
Fate Therapeutics, Inc.
United States
Fred Hutchinson Cancer Center
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.